申请人:Bayer Pharma Aktiengesellschaft
公开号:US20160244415A1
公开(公告)日:2016-08-25
Substituted uracil derivatives of formula (I), processes for their preparation, their use alone or in combinations for the treatment and/or prophylaxis of diseases, and their use for preparing medicaments for the treatment and/or prophylaxis of diseases.
公式(I)中的尿嘧啶衍生物,它们的制备方法,它们单独或组合用于治疗和/或预防疾病,以及它们用于制备治疗和/或预防疾病的药物。